期刊文献+

抑制USP22基因对人结直肠癌细胞增殖的影响

Effects of USP22 inhibition on proliferation of colorectal cancer cells
下载PDF
导出
摘要 目的 利用RNA干扰技术探讨泛素特异性肽酶22(USP22)对人结直肠癌细胞增殖的影响。方法免疫荧光检测结直肠癌组织中USP22的表达;Western blotting检测体外培养的HCT-116、SW480、HC-29结直肠癌细胞株中USP22的表达,筛选出表达量最高的细胞作为研究细胞。设计、合成针对USP22特异性siRNA,同时设置阴性对照siRNA,利用脂质体转染结直肠癌细胞后,Western blotting检测siRNA抑制效率;通过MTT法检测细胞的增殖能力;流式细胞术检测细胞的周期及凋亡;Western blotting检测周期相关蛋白CyclinB1、p21、p53、CDK2的表达。结果 结直肠癌组织中USP22表达量与癌旁组织比较,差异有统计学意义(P<0.05),结直肠癌组织中USP22表达量升高。SW480细胞中USP22的表达量最高,因此作为靶细胞进行后续研究。与对照组比较,USP22 siRNA能够降低USP22的表达(P<0.05)。USP22抑制后,与对照组比较,能够抑制SW480细胞的增殖,促使SW480细胞停滞于G0/G1期,抑制细胞周期进程,增加细胞凋亡率(P<0.05),进而抑制细胞增殖(P<0.05);同时,与对照组比较,CyclinB1、CDK2的表达量降低(P<0.05),p53和p21的表达量升高(P<0.05)。结论 USP22抑制后,能够抑制结直肠癌细胞的增殖,其机制可能与抑制细胞周期进程、促进细胞凋亡有关。 Objective To discuss the effect of ubiquitin specifc protease 22(USP22)on the growth of colorectal cancer cells.Methods The expression of USP22 in colorectal cancer tissue was detected by immunofluorescence.The expression of USP22 in the three kinds of colorectal cancer cells(HCT-116,SW480,HT-29)were detected by western blotting analysis to select the highest expressed cell line.The unique siRNA for USP22 gene and the negative control siRNA were designed and produced.After transfection,the efficiency of siRNA was detected by western blotting analysis.The cell proliferation was tested by MTT analysis.The cell cycle and apoptosis were tested by flow cytometry.The altered expressions of cell cycle related genes(CyclinB1,p21,p53,and CDK2)were detected by western blotting.Results The results of immunofluorescence showed that the expression of USP22 in cancer tissue was higher than in para-carcinoma tissue(P<0.05).With the highest USP22 expression of SW480 cells selected to further experiment,the western blotting results showed that the expression of USP22 was significantly reduced by siRNA transfection(P<0.05).Silencing USP22 could significantly suppress the proliferation of SW480 cells,and induce them to arrest during the G0/G1 in order to increasing apoptosis rate(P<0.05)and inhibiting cell proliferation(P<0.05).Meanwhile,compared to negative control group,the expression of CyclinB1 and CDK2 was significantly decreased(P<0.05),and the expression of p21 and p53 was significantly increased(P<0.05).Conclusions Silencing USP22 could suppress the proliferation of colorectal cancer cells,and the mechanism might relate to cell cycle suppression and cell apoptosis promotion.
作者 王静 赵成诚 荣婉 Jing Wang;Cheng-cheng Zhao;Wan Rong(School of Life Sciences and Technology,Wuhan University of Bioengineering,Wuhan,Hubei 430415,China;Wuhan Myhalic Biotechnology Co,LTD,Wuhan,Hubei 430212,China)
出处 《中国现代医学杂志》 CAS 2019年第21期14-19,共6页 China Journal of Modern Medicine
关键词 结直肠肿瘤 泛素特异性肽酶22 细胞增殖 细胞周期 colorectal neoplasms USP22 protein cell proliferation cell cycle
  • 相关文献

参考文献3

二级参考文献23

  • 1牛备战,陈革,李丽君,吴元德,赵玉沛.吉西他滨诱导胰腺癌细胞株SW1990的耐药作用与硫氧还蛋白还原酶活性的改变[J].中国医学科学院学报,2005,27(5):606-610. 被引量:10
  • 2Lee ILl, Kim MS,Shin JM,et al. The expression patterns of deubiquitinating enzymes, USP22 and Usp22 [J]. Gene Expr Patterns, 2006,6(3) : 277-284.
  • 3Zhuang Y, Liao Z, Yu H, et al. ShRNA-mediated silencing of the ubiquitin-specifie protease 22 gene restrained cell progression and affected the Akt pathway in nasopharyn- geal carcinoma [J]. Cancer Biology & Therapy,2014,16(1) : 88-96.
  • 4Glinsky GV, Berezovska O, Glinskii AB. Microarray analy- sis identifies a death-from-cancer signature predicting therapy failure in patients with multiple types of cancer [J]. J Clin Invest,2005,115(6) : 1505-1521.
  • 5Liu YL,Jiang SX,Yang YM,et al. USP22 acts as an onco- gene by the activation of BMI-I-mediated INK4a/ARF pathway and Akt pathway [J]. Cell Biochem Biophys,2012, 62(I) :229-235.
  • 6Liu Y,Yang Y,Xu H,et al. Implication of USP22 in the regulation of BMI-I, c-Myc, pl6INK4a, pl4ARF, and cyclin D2 expression in primary colorectal carcinomas [J]. Diagn Mol Pathol,2010,19(4) : 194-200.
  • 7Zhang XY,Varthi M,Sykes SM,et al. The putative can- cer stem cell marker USP22 is a subunit of the human SAGA complex required for activated transcription and cell-cycle progression [J]. Mol Cell, 2008,29(1) : 102-111.
  • 8Schrecengost RS,Dean JL,Goodwin JF,et al. USP22 reg- ulates oncogenic signaling pathways to drive lethal can- cer progression [J]. Cancer Res,2014,74(1) :272-286.
  • 9Liu YL,Yang YM, Xu H,et al. Aberrant expression of USP22 is associated with liver metastasis and poor prog- nosis of colorectal cancer [J]. J Surg Oncol,2011,103 (3): 283-289.
  • 10Yang M,Liu YD,Wang YY,et al. Ubiquitin-specific pro- tease 22:a novel molecular biomarker in cervical cancer prognosis and therapeutics [J]. Tumour Biol,2014,35 (2) : 929-934.

共引文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部